Bioequivalence Study to Compare Sol-Gel Technologies' 5-FU Cream With Efudex® (5-FU) Cream

Clinical trial NCT03727074 · COMPLETED

Trial details

NCT number: NCT03727074
Sponsor: Sol-Gel Technologies, Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Actinic Keratosis (AK)

Start date: 2018-12-21
Primary completion: 2019-12-19
Enrollment: 462

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.